Clinical Ink Unveils EDCXtra™
Clinical ink, a leading global technology company in the life sciences sector, has launched EDCXtra™, a cutting-edge Electronic Data Capture (EDC) system. This new platform is built upon the company’s top-tier direct data capture (DDC)/eSource framework, which has been honed over 17 years and has played a significant role in securing multiple FDA approvals. EDCXtra integrates all existing DDC functionalities into a single, user-friendly web application. It showcases Clinical ink’s renowned electronic Clinical Outcome Assessments (eCOAs) and eConsent solutions, forming a comprehensive platform that complies with Good Clinical Practice (GCP) standards.
Versatile Operation in Hybrid Mode
EDCXtra is crafted to operate in a hybrid mode, giving sites the flexibility to input Case Report Form (CRF) data in real-time alongside intricate eCOAs within one interface. Additionally, sites have the option to use paper CRF transcription methods and enter the data into the EDC system at a later stage. This flexibility boosts operational efficiency and caters to the varied demands of clinical trials.
Improved Integration Features
The EDCXtra platform not only supports electronic consent (eConsent) but also allows integration through API with other eClinical systems, such as interactive response technology (IRT) and laboratory data systems. This highly customizable solution can be adapted to meet the specific needs of each trial, providing researchers and sponsors with unmatched flexibility and control over their data.
Enhancing the Site Experience
"We created EDCXtra to enhance the site experience by offering a single, adaptable EDC/DDC solution," stated Megan Petrylak, EVP of Clinical Operations at Clinical Ink. "Integrating EDCXtra into our complete eClinical suite accelerates data capture speed and quality while significantly reducing the administrative load on sites. Sponsors gain from the simplicity and cost-effectiveness of a unified study design for EDC and complex eCOAs, along with the customizable integration of third-party data systems like IRT and central laboratories.”
About Clinical Ink
Clinical ink is a global life science organization dedicated to merging data, technology, and patient-centered research. Their vast therapeutic knowledge, paired with innovations in EDC, DDC, eCOA, eConsent, telehealth, and digital biomarkers—such as using Blood and Continuous Glucose Monitoring to identify hypoglycemia—propels the advancement of the next generation of clinical trials and improves clinical patient management.
Frequently Asked Questions
What is EDCXtra™?
EDCXtra™ is an advanced Electronic Data Capture system launched by Clinical ink, aimed at simplifying the process of collecting clinical data.
How does EDCXtra™ enhance trial efficiency?
EDCXtra™ facilitates real-time data entry and consolidates various functionalities into one platform, thereby boosting overall trial efficiency.
Can EDCXtra™ be tailored for specific trials?
Absolutely, EDCXtra™ is fully customizable to meet the unique requirements of individual clinical trials.
What advantages does EDCXtra™ offer for clinical sites?
EDCXtra™ alleviates administrative burdens and improves the site experience by providing a cohesive solution for data capture.
How does Clinical ink support clinical trials?
Clinical ink merges technological advancements with therapeutic expertise to facilitate and enhance the conduct of clinical trials.